tacrolimus capsule
watson laboratories, inc. - tacrolimus (unii: wm0haq4wnm) (tacrolimus anhydrous - unii:y5l2157c4j) - tacrolimus anhydrous 5 mg
tacrolimus capsule
kaiser foundation hospitals - tacrolimus (unii: wm0haq4wnm) (anhydrous tacrolimus - unii:y5l2157c4j) - tacrolimus 1 mg
tacrolimus capsule
cardinal health - tacrolimus (unii: wm0haq4wnm) (tacrolimus anhydrous - unii:y5l2157c4j) - tacrolimus 1 mg
prograf- tacrolimus capsule, gelatin coated
rebel distributors corp - anhydrous tacrolimus (unii: y5l2157c4j) (tacrolimus - unii:wm0haq4wnm) - anhydrous tacrolimus 1 mg - prograf is indicated for the prophylaxis of organ rejection in patients receiving allogeneic liver, kidney, or heart transplants. it is recommended that prograf be used concomitantly with adrenal corticosteroids. because of the risk of anaphylaxis, prograf injection should be reserved for patients unable to take prograf capsules orally. in heart and kidney transplant recipients, it is recommended that prograf be used in conjunction with azathioprine or mycophenolate mofetil (mmf). the safety and efficacy of the use of prograf with sirolimus has not been established (see clinical studies). prograf is contraindicated in patients with a hypersensitivity to tacrolimus. prograf injection is contraindicated in patients with a hypersensitivity to hco-60 (polyoxyl 60 hydrogenated castor oil).
advagraf prolonged release hard capsules 0.5 mg
astellas pharma singapore pte. ltd. - tacrolimus monohydrate 0.51 mg eqv anhydrous tacrolimus 0.5 mg - capsule, extended release - 0.5 mg - tacrolimus monohydrate 0.51 mg eqv anhydrous tacrolimus 0.5 mg 0.5 mg
advagraf prolonged release hard capsules 1 mg
astellas pharma singapore pte. ltd. - tacrolimus monohydrate 1.02 mg eqv anhydrous tacrolimus 1.0 mg - capsule, extended release - 1.0 mg - tacrolimus monohydrate 1.02 mg eqv anhydrous tacrolimus 1.0 mg 1.0 mg
advagraf prolonged release hard capsules 5 mg
astellas pharma singapore pte. ltd. - tacrolimus monohydrate 5.1 mg eqv anhydrous tacrolimus 5.0 mg - capsule, extended release - 5.0 mg - tacrolimus monohydrate 5.1 mg eqv anhydrous tacrolimus 5.0 mg 5.0 mg
rapamune tablet 2 mg
pfizer private limited - (active filler coat) sirolimus @ 100% - tablet, sugar coated - 2.0 mg - (active filler coat) sirolimus @ 100% 2.0 mg
rapamune oral solution 1 mgml
pfizer private limited - sirolimus - solution - 1 mg/ml - sirolimus 1 mg/ml
rapamune tablet 1 mg
pfizer private limited - (active filler coat) sirolimus @ 100% - tablet, sugar coated - 1.00 mg - (active filler coat) sirolimus @ 100% 1.00 mg